When a doctor tells you that your child or spouse needs a bone marrow transplant, the first question is rarely about the procedure itself. It is about survival. About whether it will actually work. About whether travelling all the way to India is worth the risk, the money, and the emotional toll on your family.

This article looks honestly at bone marrow transplant success rates in India — what the numbers actually mean, what drives them up or down, and what Nigerian families should realistically expect before making a decision.

This is not a promotional piece. It will not promise miracles. But it will give you the information you need to ask better questions and make a more informed choice.

What Does “Success Rate” Actually Mean?

This part is important, because the term gets used loosely.

When hospitals talk about success rates, they usually mean one of three things: the transplant took hold (engraftment), the patient survived past 100 days, or the patient is alive and in remission at one or five years. These are very different numbers, and comparing them across hospitals or countries without knowing which definition is being used leads to confusion.

For bone marrow transplants in India, reputable transplant centres report engraftment success rates of 85–95% for related donor transplants in younger patients with conditions like thalassemia or aplastic anaemia. For leukaemia, overall survival at five years depends heavily on disease type and stage at the time of transplant — generally ranging between 40% and 70% for standard-risk patients.

These figures are broadly comparable to what you would find in well-resourced hospitals in the UK or the Gulf states, which is why India has become a serious destination for families in Nigeria and across Africa.

Factors That Most Affect Outcomes

Success rates are not fixed. They shift depending on several variables, and as a family, some of these are within your control.

Diagnosis and disease stage. A patient transplanted in early remission consistently does better than one transplanted after relapse. If treatment has already been attempted in Nigeria and has failed, the numbers do become more difficult. This is not a reason to abandon hope — but it is a reason to act quickly and not delay the decision.

Patient age and overall health. Younger patients and those without major organ complications tolerate the procedure better. Children with inherited blood disorders like sickle cell disease or thalassemia generally have strong outcomes when transplanted early.

Donor match quality. A fully matched sibling donor gives the best results. When no matched sibling is available, hospitals use matched unrelated donors from registries or haploidentical (half-match) transplants from parents. These alternatives have improved significantly over the last decade but still carry higher complication rates.

Hospital and transplant team experience. A bone marrow transplant is not just a procedure. It is weeks of post-transplant care, managing infections, monitoring for graft-versus-host disease, and adjusting medications in real time. The team behind the transplant matters as much as the transplant itself.

How Nigeria-Specific Factors Come Into Play

Most Nigerian patients arrive at Indian hospitals after a period of treatment back home, which means some degree of disease progression has already occurred. This is a reality that experienced transplant teams in India understand well.

It is worth acknowledging directly: bone marrow transplant services in Nigeria are limited. Very few centres perform the full allogeneic transplant procedure, and access to matched unrelated donor registries is extremely restricted. For many Nigerian families, India is not just a cheaper option — it is the only realistic path to a transplant that their loved one actually needs. Indian transplant teams working with NABH and JCI-accredited facilities have treated patients from Lagos, Abuja, Port Harcourt, and across West Africa for years, and most have international patient coordinators who understand the specific challenges involved.

What changes when you travel for a transplant:

The pre-transplant workup gets done in India, often within the first week of arrival. Teams assess organ function, infectious disease history, and donor compatibility in parallel, which speeds up the process considerably compared to fragmented care across multiple facilities.

Some Nigerian patients carry infections like malaria or hepatitis B that require management before conditioning begins. Good transplant teams factor this into the protocol and have experience doing so.

The transplant stay for an autologous (using the patient’s own cells) procedure is typically 4–6 weeks. An allogeneic (donor) transplant, which is more common for blood cancers and inherited disorders, typically requires 6–10 weeks in India. Many hospitals now offer remote consultations before you travel, so you can get a full assessment and a cost estimate without booking flights first.

If you want help connecting with a transplant centre that has experience with Nigerian patients specifically, ask a transplant specialist on WhatsApp — we can point you in the right direction before you contact any hospital directly.

Success Rates by Condition: A Practical Overview

Rather than quoting a single number, here is a condition-by-condition breakdown that gives a clearer picture.

Thalassemia major (in children): Among the best outcomes. When transplanted from a matched sibling in early childhood, disease-free survival rates above 85% are well-documented. India has treated thousands of thalassemia patients from across the world with strong long-term results.

Aplastic anaemia: Outcomes with a matched sibling donor are excellent — disease-free survival above 80% is consistently reported in younger patients. Unrelated donor transplants carry more risk but are improving.

Acute leukaemia (ALL/AML): More variable. First complete remission transplants in standard-risk patients yield five-year survival in the 50–65% range. High-risk and relapsed cases are lower, but transplant can still offer the best available chance.

Sickle cell disease: India has increasing experience here, particularly with haploidentical transplants. Outcomes in children have improved, with cure rates above 75% reported in select centres for matched sibling transplants.

Lymphoma: For Hodgkin’s and non-Hodgkin’s lymphoma requiring autologous transplant, outcomes are generally strong — event-free survival above 60–70% in chemosensitive disease.

If your family member’s condition is not on this list, it is worth speaking to a transplant team directly. Chat with us on WhatsApp and we can connect you with the right specialists to get an accurate picture for your specific situation.

Why Indian Hospitals Are Able to Offer Competitive Outcomes

This is not about marketing. There are structural reasons why outcomes in top Indian transplant centres are comparable to international benchmarks.

Indian hospitals accredited by NABH and JCI are held to rigorous protocols. Transplant units are designed specifically for this purpose — with HEPA-filtered isolation rooms, dedicated nursing teams trained in BMT care, and pharmacy units that compound chemotherapy on site.

The volume of transplants performed matters enormously. A centre doing 100 or more transplants per year develops the institutional knowledge to catch complications early, to manage rare graft failures, and to support families who are far from home.

Cost is also a factor. A bone marrow transplant in India typically costs a fraction of what the same procedure would cost in the UK or US, without compromising on medical standards. This makes it possible for more Nigerian families to access care that is simply not affordable elsewhere.

Frequently Asked Questions

Can a Nigerian patient get the same success rates as a local Indian patient? Generally, yes — assuming equivalent disease stage and donor match. Nationality does not affect transplant biology. What matters is the clinical picture at the time of transplant, which is why early consultation is so important.

Is it safe to travel to India for a bone marrow transplant? Yes, when the travel is planned carefully. Most families travel after the initial consultation is done remotely and a transplant date is already booked. You are not going to explore — you are going for a scheduled procedure with a team that already knows your case. Many hospitals offer video consultations so you can speak with the transplant doctor before you leave Nigeria.

What happens if there is no matched sibling donor? Indian hospitals have access to international bone marrow registries and are experienced with haploidentical transplants using a parent as donor. This is now a well-established alternative and the results have improved substantially over the past decade.

How long do we need to stay in India? This depends on the type of transplant and how the patient responds. Plan for a minimum of 6–8 weeks on the ground, with the possibility of extending if complications occur.

Is post-transplant follow-up possible from Nigeria? To a degree. Many centres offer structured remote follow-up for stable patients, and some have experience coordinating with haematologists in Nigeria. The first 100 days post-transplant are the most critical, and most teams prefer the patient to remain accessible to the hospital during this period — either in India or in close contact with a local doctor who they can advise in real time. It is manageable. Families navigate it every year. The important thing is to plan it in advance rather than improvise.

What should we bring to the first consultation? All previous medical records — pathology reports, imaging, prior treatment history, donor blood group and basic HLA typing if available. The more complete your records, the faster the transplant team can give you a realistic assessment.

What to Do Next

If you have read this far, you are already doing the right thing. Understanding what success rates mean, rather than just accepting a percentage at face value, gives you the ability to ask better questions and make a more informed decision.

The next step is a direct consultation with a transplant team. This can usually be done remotely, using your existing medical records, within one to two weeks.

If you want support navigating that process — finding the right hospital, understanding the cost estimates, or preparing for the consultation — we are here to help. Send us a WhatsApp message and we will guide you through the next step.

The information in this article is for general guidance only. Medical decisions should always be made in consultation with a qualified transplant specialist who has reviewed your full medical history.